{"nct_id":"NCT05176639","title":"A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE )","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2021-12-03","start_date_type":"ACTUAL","primary_completion_date":"2024-07-15","primary_completion_date_type":"ACTUAL","completion_date":"2025-03-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["VRDN"]}